Fadogia Agrestis and Fadogia Agrestis for Testosterone (humans)
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Compound or practice
Fadogia Agrestis
A trendy testosterone herb with essentially zero human data and animal toxicity signals — not worth the risk.
Grade D1 graded outcomerevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Evidence brief
Fadogia Agrestis for Testosterone (humans)
Evidence grade D — No human trials
Grade D1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Fadogia Agrestis | Fadogia Agrestis for Testosterone (humans) |
|---|---|---|
| Testosterone (humans) | Evidence grade DUnclear effectlowNo human trials | Evidence grade DUnclear effectlowNo human trials |
Graded only in Fadogia Agrestis
None — every outcome it grades is graded in both.
Graded only in Fadogia Agrestis for Testosterone (humans)
None — every outcome it grades is graded in both.
What each entry says about the other
- Fadogia Agrestis for Testosterone (humans)’s entry · Goes with: Read the full Fadogia Agrestis monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.